Sanger and Nelson (1989)
Selective and functional 5-hydroxytryptamine3 receptor antagonism by
BRL 43694 (granisetron). Eur.J.Pharmacol. 159 113. Plosker and
Goa (1991) Granisetron. A review of its pharmacological properties and
therapeutic use as an antiemetic. Drugs 42 805. Martinet
al (1998) Anti-emetic effect of Ondansetron and Granisetron after exposure
to mixed neutron and gamma irradiation. Rad.Res. 149 631.
Atypical antipsychotic agent that displays 5-HT2A receptor antagonism. Also displays high affinity at D2 receptors (Ki values are 0.4 and 3.13 nM for 5-HT2A and D2 receptors respectively).